Company Filing History:
Years Active: 1994-1996
Title: Nanda K Gulavita: Innovator in Antitumor and Antibacterial Peptides
Introduction
Nanda K Gulavita is a notable inventor based in Palm Bay, Florida, recognized for his contributions to the field of biotechnology. He has been instrumental in the development of novel peptides that hold promise in medical applications, particularly in combating cancer and bacterial infections. With a total of two patents to his name, Gulavita's work exemplifies the intersection of marine biology and pharmaceutical innovation.
Latest Patents
Gulavita's latest patents include significant advancements in the use of peptides derived from marine sources. The first patent, titled "Antitumor and antibacterial peptide and methods of use," describes a novel peptide known as polydiscamide A, which has been isolated from a marine sponge. This compound, along with its derivatives, has shown potential as both antibacterial and antitumor agents. The second patent, "Antibacterial peptide and methods of use," focuses specifically on the antibacterial properties of polydiscamide A, highlighting its effectiveness in fighting bacterial infections.
Career Highlights
Nanda K Gulavita is affiliated with the Harbor Branch Oceanographic Institution, Inc., where he conducts research that bridges marine science and health applications. His work has contributed to a deeper understanding of how marine organisms can be harnessed for therapeutic purposes. Gulavita's innovative approach has positioned him as a key figure in the field of peptide research.
Collaborations
Throughout his career, Gulavita has collaborated with esteemed colleagues, including Sarath P Gunasekera and Shirley A Pomponi. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the study of marine-derived compounds.
Conclusion
Nanda K Gulavita's contributions to the field of biotechnology through his innovative peptide research underscore the potential of marine organisms in developing new therapeutic agents. His work not only advances scientific knowledge but also holds promise for future medical applications.